|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 31/4545 | (2006.01) |
| A61K 31/4545 | (2013.01) | ||
| A61P 27/02 | (2006.01) | ||
| A61P 27/02 | (2018.01) |
| (11) | Patento numeris | 3763369 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 20174399.4 |
| Europos patento paraiškos padavimo data | 2013-04-02 | |
| (97) | Europos patento paraiškos paskelbimo data | 2021-01-13 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2024-02-28 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (30) | Numeris | Data | Šalis |
| 12162937 | 2012-04-03 | EP |
| (72) |
NIVENS, Michael Chadham , DE
BOUYSSOU, Thierry , DE
GOEGGEL, Rolf , DE
SEITHER, Peter , DE
|
| (73) |
Alkahest, Inc. ,
125 Shoreway Road, Suite D, San Carlos, CA 94070,
US
|
| (54) | USE OF CCR3-INHIBITORS FOR TREATING DRY AGE-RELATED MACULAR DEGENERATION |
| USE OF CCR3-INHIBITORS FOR TREATING DRY AGE-RELATED MACULAR DEGENERATION |